Push launch MHRA approves GLP –one receptor agonist semaglutide to lessen possibility of serious coronary heart troubles in obese or overweight Grown ups Semaglutide is the initial fat loss drug authorized in the UK like a preventative treatment for the people with recognized heart problemsIn experiments with rodents, Wegovy® and medicines that